Pamela J. Cramer
Known title: Chief Human Resources OfficerCIK: 0001873517
Associated companies
Transaction History
| RYTM | ▲ Buy | Option Exercise | 13,293 | — | 2/1/2026 | View on chart |
| RYTM | ▼ Sell | Tax Withholding | 4,731 | $516K | 2/1/2026 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,350 | $92K | 12/11/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,350 | $372K | 12/11/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,350 | $92K | 11/20/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,350 | $352K | 11/20/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,515 | $24K | 11/10/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,515 | $352K | 11/10/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 10,546 | $72K | 11/7/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 8,805 | $167K | 11/7/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 19,351 | $1.9M | 11/7/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,520 | $131K | 7/29/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,125 | — | 7/26/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 4,225 | $319K | 7/9/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 7,831 | $601K | 7/9/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,516 | $281K | 7/9/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 10,547 | $72K | 7/9/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 5,025 | $137K | 7/9/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 7,031 | $478K | 6/6/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 7,031 | $48K | 6/6/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 7,031 | $458K | 4/29/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 7,031 | $48K | 4/29/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 6,700 | $183K | 4/8/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 600 | $35K | 4/8/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 6,700 | $402K | 4/8/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 6,430 | $375K | 4/8/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 14,060 | $96K | 4/8/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 7,030 | $436K | 4/8/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 982 | $56K | 2/19/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,300 | — | 2/16/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 698 | $40K | 2/11/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 3 | $173 | 2/11/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,344 | — | 2/9/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 902 | $54K | 2/4/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,650 | — | 2/1/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,688 | $89K | 11/7/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 4,688 | $305K | 11/7/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,687 | $89K | 11/6/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 4,687 | $281K | 11/6/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,099 | $78K | 9/9/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 4,099 | $205K | 9/9/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,200 | $61K | 8/26/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,200 | $160K | 8/26/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 30,771 | $585K | 8/9/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 46,902 | $2.1M | 8/9/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 2,104 | $96K | 8/9/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,395 | $68K | 7/29/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,125 | — | 7/26/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 15,515 | $608K | 3/19/2024 | View on chart |
| RYTM | ▲ Buy | Grant | 33,750 | $0 | 2/16/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 696 | $36K | 2/12/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,344 | — | 2/9/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,650 | — | 2/1/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 946 | $43K | 2/1/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,125 | — | 7/26/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 930 | $16K | 7/26/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 834 | $23K | 2/9/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,344 | — | 2/9/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 13,493 | $257K | 8/19/2022 | View on chart |
| RYTM | ▼ Sell | Open Market | 13,493 | $335K | 8/19/2022 | View on chart |
| RYTM | ▼ Sell | Open Market | 901 | $11K | 7/27/2022 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,125 | — | 7/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
RYTM: RBC raises price target to $159, maintains Outperform
RBC Capital kept its Outperform rating on Rhythm Pharmaceuticals and lifted its price target to $159. The new target sits well above the stock’s 52‑week high of $122.20 and higher than the consensus analyst target of $138.59. A recent Benzinga piece also highlighted the stock’s five‑year total return, underscoring its past performance. These developments may influence market perception of the company’s growth prospects.
RYTM: RBC raises price target to $159, maintains Outperform. RBC Capital kept its Outperform rating on Rhythm Pharmaceuticals and lifted its price target to $159. The new target sits well above the stock’s 52‑week high of $122.20 and higher than the consensus analyst target of $138.59. A recent Benzinga piece also highlighted the stock’s five‑year total return, underscoring its past performance. These developments may influence market perception of the company’s growth prospects.